Cover Image
市場調查報告書

醫藥品市場ICT投資趨勢:企業的ICT支出模式預測

ICT investment trends in pharmaceuticals ; Enterprise ICT spending patterns through to the end of 2016

出版商 Kable 商品編碼 314911
出版日期 內容資訊 英文 83 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
醫藥品市場ICT投資趨勢:企業的ICT支出模式預測 ICT investment trends in pharmaceuticals ; Enterprise ICT spending patterns through to the end of 2016
出版日期: 2015年11月27日 內容資訊: 英文 83 Pages
簡介

本報告依據113家製藥企業的資訊通訊技術(ICT)的投資趨勢相關調查結果為基礎,提供在企業的ICT支出核心領域(硬體設備、軟體、IT服務、通訊、諮詢)如何分配ICT預算、現狀相關驗證等,有系統的資訊。

第1章 ICT預算趨勢

  • 簡介
  • 調查人口統計
  • ICT預算的變化
  • ICT預算的分配:各核心技術領域
    • 硬體設備預算的明細
    • 軟體預算的明細
    • 第三方IT服務支出
    • 通訊預算
  • ICT預算的分配:各功能
  • IT功能的外包

第2章 ICT投資的優先順序和供應商的顧客購買傾向率

  • 簡介
    • 商業智慧(BI)
    • 內容管理
    • 雲端運算

第3章 ICT採購趨勢

  • 簡介
  • 影響IT投資策略的業務目標
  • 影響IT投資策略的IT目標
  • ICT供應商的選擇

第4章 各部門趨勢

  • 簡介
  • 固有的事業領域的IT支出計劃
  • 最大的投資事業領域
  • 商務課題

第5章 摘要

  • 為了維持市場上的競爭力,日益重視IT

第6章 附錄

  • 定義
  • 相關調查
  • 聯絡處

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: KG0189CI

Summary

The pharmaceutical industry is in the midst of fundamental changes, brought on by the increasing concerns over the expiry of patents, weak product pipelines, and competition from generics. However, increasing prosperity in emerging markets is creating new avenues for pharmaceutical companies to increase their top-line growth. Thus, to meet the challenges and exploit the opportunities, pharmaceutical companies are increasingly looking towards advanced technologies to stay ahead of the intense competition in the field.

Key Findings

To offset declining sales from the patent cliff, companies are expanding into emerging markets in order to increase their market share, which is in turn leading to increasing investments in their core ICT categories of hardware, software, and IT services.

Kable expects mobility and cloud computing to gain momentum in the next two years, and companies are set to increase spending on these advance technologies in order to enhance their competitiveness.

Meanwhile, pharmaceutical companies are prioritizing their ICT investments relating to clinical and pre-clinical research to drive future RandD requirements.

Synopsis

ICT investment trends in pharmaceuticals presents the findings from a survey of 95 pharmaceutical companies regarding their Information and Communications Technology (ICT) investment trends. The survey investigates how pharmaceutical companies currently allocate their ICT budgets across the core areas of enterprise ICT expenditure: hardware, software, IT services, communications, and consulting.

The report illustrates the core technologies banks are investing in, including business intelligence, mobility and cloud computing. Understand the approach adopted by pharmaceutical companies to purchase technology and get a better insight into ICT vendors and services providers when pitching their solutions to pharmaceutical companies. The report also focuses on pharmaceutical companies' ICT spending trends for specific business systems, identifying the top three IT projects, and understanding the business challenges faced by companies.

In particular, it provides an in-depth analysis of the following:

  • How ICT budgets are set to change in 2015 in terms of their overall size
  • Allocation across the core elements of IT spend, including hardware, software, services, communications, and consulting
  • Distribution of ICT money in areas such as the networks, applications, service desk, and data centers
  • Which ICT functions pharmaceutical companies are interested in outsourcing
  • Pharmaceuticals' investment priorities based on their budget allocations across core technology categories such as business intelligence, mobility, and cloud computing
  • Factors that are influencing pharmaceutical companies' investments in each technology category
  • How pharmaceutical companies' IT budgets are currently allocated across various segments within a technology category
  • Pharmaceutical companies' distribution of their ICT budget across various segments within a technology category
  • Vendor satisfaction ratings for various core and advanced technology categories
  • Insight into pharmaceutical companies' preferred buying approaches
  • Business and IT objectives that pharmaceutical companies are looking to achieve through their IT investment strategies
  • Factors that are influencing pharmaceutical companies' decisions to select an ICT provider

Reasons To Buy

  • Understand how the pharmaceutical companies ICT landscape is set to change in 2015 to prioritize your target market
  • Comprehend how ICT money are being allocated by pharmaceutical companies in specific geographies and size bands to improve your market penetration
  • Make effective business decisions by recognizing the opportunities within each of the core areas of ICT spend (hardware, software, IT services, telecommunications, and consulting)
  • Realign your sales initiatives by understanding the current strategic objectives of pharmaceutical companies
  • Enhance your market segmentation with the included, detailed breakdown of opportunities within selected technology categories (business intelligence, mobility, and cloud computing)
  • Prioritize your focus areas by understanding which factors are influencing pharmaceutical companies' decisions when selecting an ICT provider
  • Understand the changes in customers' priorities and identify the business and IT objectives that pharmaceutical companies are looking to achieve through their ICT investment strategies

Table of Contents

1. Trends in ICT budgets

  • 1.1. Introduction
  • 1.2. Survey demographics
  • 1.3. ICT budget changes
  • 1.4. ICT budget allocation by core technology area
    • 1.4.1. Hardware budget breakdown
    • 1.4.2. Software budget breakdowns
    • 1.4.3. Third party IT services expenditure
    • 1.4.4. Cloud computing budget
  • 1.5. ICT budget allocation by function
  • 1.6. Outsourced IT functions

2. ICT investment priorities and vendor satisfaction

  • 2.1. Introduction
    • 2.1.1. Business intelligence
    • 2.1.2. Mobility
    • 2.1.3. Cloud computing

3. ICT procurement trends

  • 3.1. Introduction
  • 3.2. Business objectives and IT objectives influencing IT investment strategy
  • 3.3. ICT provider selection

4. Sector-specific trends

  • 4.1. Introduction
  • 4.2. IT expenditure plans for specific technology areas
  • 4.3. Business areas receiving the largest investments
  • 4.4. Business challenges

5. Summary

  • 5.1. Pharmaceutical companies are increasingly looking towards advanced technologies to stay ahead of the intense competition

6. Appendix

  • 6.1. Definitions
  • 6.2. Further reading
  • 6.3. Contact the authors

List of Figures

  • Figure 1: Pharmaceuticals - ICT survey geographic breakdown
  • Figure 2: Pharmaceuticals - ICT survey breakdown by size band (number of employees)
  • Figure 3: Recent and expected ICT budget changes among pharmaceutical companies
  • Figure 4: Pharmaceutical companies' (external) ICT budget allocation, 2014 and 2015
  • Figure 5: Pharmaceutical companies' average hardware budget allocation
  • Figure 6: Average allocation of software budgets in pharmaceutical companies
  • Figure 7: Pharmaceutical companies' average IT services budget allocation
  • Figure 8: Pharmaceutical companies' average cloud computing budget allocation by technology
  • Figure 9: Pharmaceutical companies' average cloud computing budget allocation by implementation type...
  • Figure 10:Pharmaceutical companies' ICT budget allocation by function, 2014 and 2015
  • Figure 11: Outsourced IT functions - Pharmaceutical companies' current and future outsourcing priorities
  • Figure 12: Business intelligence -Pharmaceutical companies' current and future investment priorities
  • Figure 13: Business intelligence - selected primary provider and vendor satisfaction among pharmaceutical companies
  • Figure 14:Mobility - Pharmaceutical companies' current and future investment priorities
  • Figure 15:Mobility - selected primary provider and vendor satisfaction among pharmaceutical companies.
  • Figure 16: Cloud computing - Pharmaceutical companies' current and future investment priorities
  • Figure 17: Cloud computing - selected primary provider and vendor satisfaction among pharmaceutical companies
  • Figure 18: Business objectives and IT objectives which influence pharmaceutical companies' IT investment strategy
  • Figure 19: Factors influencing pharmaceutical companies' decision to choose an ICT provider
  • Figure 20: IT expenditure plans in 2015 compared to 2014, for specific technology areas within pharmaceutical companies
  • Figure 21: Top three IT projects in 2015 for pharmaceutical companies
  • Figure 22: Importance of the following business challenges for pharmaceutical companies
Back to Top